Monitoring asparaginase activity in middle-income countries

Lancet Oncol. 2018 Sep;19(9):1149-1150. doi: 10.1016/S1470-2045(18)30584-9. Epub 2018 Aug 2.
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / blood
  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / standards
  • Asparaginase / administration & dosage
  • Asparaginase / blood
  • Asparaginase / pharmacology*
  • Asparaginase / standards
  • Brazil
  • Drug Administration Schedule
  • Drug Compounding
  • Drug Monitoring / methods*
  • Drug Monitoring / standards
  • Humans
  • Infusions, Parenteral
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Quality Control
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Asparaginase